News of Note—Emergent BioSolutions and GeoVax

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Emergent BioSolutions filed for an FDA emergency use authorization for its anthrax vaccine NuThrax. Release

> GeoVax teamed up with Enesi Pharma to develop vaccines on a needle-free delivery platform. Release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.